Edition:
United States

People: Landec Corp (LNDC.O)

LNDC.O on Nasdaq

10.53USD
16 Jul 2019
Change (% chg)

-- (--)
Prev Close
$10.53
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
154,409
52-wk High
$15.57
52-wk Low
$9.02

Powell, Andrew 

Mr. Andrew Kenneth William Powell J.D. serves as Interim Chairman of the Board of the company. Mr. Powell is currently serving as an independent advisor to small and mid-size companies and research institutions in the life sciences sector. He has served on the Board of Directors of Aclaris Therapeutics, Inc., a dermatologist-led biopharmaceutical company, since 2017. He served as Senior Vice President, General Counsel and Corporate Secretary of Medivation, Inc. from May 2015 until November 2016, when the company was acquired by Pfizer, Inc. Mr. Powell served as Executive Vice President, General Counsel and Corporate Secretary of InterMune, Inc. from September 2013 to March 2015. From 2009 to 2013, he served as Executive Vice President, General Counsel and Secretary at Cornerstone Therapeutics, Inc. From 2008 to 2009, Mr. Powell served as Senior Vice President and General Counsel at ImClone Systems, Inc. From 2004 to 2008, he was General Counsel at Collagenex Pharmaceuticals, Inc. Earlier in his career, Mr. Powell held positions of increasing responsibility for nearly 15 years at the multi-national healthcare company Baxter International, Inc., where he was instrumental in a series of transactions that established Baxter throughout Asia. Mr. Powell holds a Bachelor of Arts degree from the University of North Carolina at Chapel Hill and a J.D. from Stanford Law School.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Andrew Powell

--

Albert Bolles

137,500

Gregory Skinner

728,934

James Hall

1,028,410

Tim Burgess

--

Steven Bitler

372,309
As Of  26 May 2018